Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Brazil

Stada Out, But Emerging Markets Move Up Teva's Wish List

September 2008 | Company News Alert

Israel's Teva Pharmaceutical Industries has moved to end speculation that it is eying up an acquisition of Germany's Stada Arzneimittel. Teva's North American CEO William Marth stated 'I currently don't think that would be a good acquisition for us', when quizzed at the Generic Pharmaceutical Association (GPhA) Annual Policy Conference in

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Umckaloabo Patents Challenged

Companies / Germany Highlighting the legal minefield of bioprospecting, Germany's Schwabe Pharmaceuticals is facing a challenge to two European Patent Office (EPO) patents for its phytopharmaceutical Umckaloabo, which is...
May 2008
ARV Manufacturing Gets Green Light

Companies / Brazil A long-delayed pharmaceutical plant that would provide Mozambique with the capacity to manufacture generic antiretrovirals (ARVs) looks set to be built with support from the Brazilian government. Back...
January 2008
Bioprospecting: A Source Of Protection Or Destruction?

Companies / Brazil Less developed nations are becoming increasingly aware of the value of their natural resources. While traditionally this has meant more obvious resources such as oil and gas and mineral deposits, many...
October 2007
Teva, Mylan Compete For Merck KGaA's Generics Arm

Companies / Germany The race for the generics business of Germany's Merck KGaA looks to be heading into the final stages with two firms thought to be leading the bidding - Israel's Teva , and US-based Mylan. At...
May 2007
Merck KGaA To Divest Generics Business?

Companies / Germany German drugmaker
January 2007
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS